Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Frontiers in Oncology|August 1, 2022
Targeting strategies in the treatment of fumarate hydratase deficient renal cell carcinomaAndrea Katharina Lindner, Gennadi Tulchiner, Andreas Seeber, et al.
Frontiers in Immunology|March 25, 2017
Metabolic Hallmarks of Tumor and Immune Cells in the Tumor MicroenvironmentKathrin Renner, Katrin Singer, Gudrun E Koehl, et al.
International Journal of Molecular Sciences|April 3, 2021
Heat-Inactivation of Human Serum Destroys C1 Inhibitor, Pro-motes Immune Complex Formation, and Improves Human T Cell FunctionMatthias A Fante, Sonja-Maria Decking, Christina Bruss, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2025
The CD70-CD27 axis in cancer immunotherapy: Predictive biomarker and therapeutic targetIkuan Sam, Nadine Ben Hamouda, Marina Alkatrib, et al.
Cancer Immunology Research|September 14, 2018
Stromal Fibroblasts Mediate Anti-PD-1 Resistance via MMP-9 and Dictate TGFβ Inhibitor Sequencing in MelanomaFei Zhao, Kathy Evans, Christine Xiao, et al.
Frontiers in Immunology|March 18, 2026
Increased expression of CD36 and CD163 in clear cell renal cell carcinoma suggests an association between lipid transport and an "M2-like" macrophage phenotypeYosra Bouraoui, Rahma Said, Christina Bruss, et al.
Frontiers in Immunology|April 3, 2023
A chemokine network of T cell exhaustion and metabolic reprogramming in renal cell carcinomaRenate Pichler, Peter J Siska, Piotr Tymoszuk, et al.
Journal of Immunological Methods|September 6, 2016
Fluorescence-based measurement of cystine uptake through xCT shows requirement for ROS detoxification in activated lymphocytesPeter J Siska, Bumki Kim, Xiangming Ji, et al.
Journal of Cachexia, Sarcopenia and Muscle|December 11, 2025
Interplay of IL-6, GDF-15 and Sarcopenia in Patients With Bladder Cancer Undergoing Radical Cystectomy and Its Implications on SurvivalSimon U Engelmann, Felix Kasparbauer, Christoph Pickl, et al.
Frontiers in Oncology|February 13, 2023
Low-density lipoprotein balances T cell metabolism and enhances response to anti-PD-1 blockade in a HCT116 spheroid modelNathalie Babl, Joshua Hofbauer, Carina Matos, et al.
Pageof 5